Page last updated: 2024-12-11
xantocillin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
xantocillin: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 5378293 |
CHEMBL ID | 1977264 |
SCHEMBL ID | 3773785 |
SCHEMBL ID | 4264133 |
MeSH ID | M0475772 |
Synonyms (55)
Synonym |
---|
unii-06z55vz40d |
4-13-00-02885 (beilstein handbook reference) |
xantocillin [inn:ban] |
xantocilline |
06z55vz40d , |
einecs 234-271-3 |
unii-ex637i77pc |
11042-38-9 |
ex637i77pc , |
xantocilline [inn-french] |
1,4-di-p-oxyphenyl-2,3-di-isonitrilo-1,3-butadien |
xantocillinum [inn-latin] |
xanthocillinum |
xantocillin [inn] |
brn 3700094 |
antibiotic obtained from cultures of penicillium notatum or the same substance produced by any other means |
xantocilina [inn-spanish] |
nsc-227183 |
ophthocillin |
ethylene isocyanide, bis(p-hydroxybenzylidene)- |
brevicide-x |
nsc-179485 |
xantocillin |
trianthil |
phenol,4'-(2,3-diisocyano-1,3-butadiene-1,4-diyl)bis- |
xanthocillin (x) |
1,3-di-isonitrilo-1,3-butadien |
nsc227183 |
xanthocillin x |
nsc179485 |
580-74-5 |
brevicide |
brevicid |
xantyrid |
wln: qr d1uynu1&ynu1&u1r dq |
xanthocillin |
SCHEMBL3773785 |
4-[(1z,3z)-4-(4-hydroxyphenyl)-2,3-diisocyanobuta-1,3-dienyl]phenol |
xantocillinum |
xantocilina |
CHEMBL1977264 |
(1z, 3z)-2,3-diisocyano-1,4-bis(4-hydroxyphenyl)buta-1,3-diene |
4,4'-((1z,3z)-2,3-diisocyano-1,3-butadiene-1,4-diyl)bisphenol |
xanthocillin x [mi] |
1,4-bis(p-hydroxyphenyl)-2,3-diisonitrilo-1,3-butadiene |
xantocillin [who-dd] |
(1z,3z)-2,3-diisocyano-1,4-bis(4-hydroxyphenyl)buta-1,3-diene |
SCHEMBL4264133 |
DTXSID801018149 |
CS-0085072 |
HY-122404 |
brevicide, xanthocillin x |
BS-1175 |
4,4'-((1z,3z)-2,3-diisocyanobuta-1,3-diene-1,4-diyl)diphenol |
AKOS040742829 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (10)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 4 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 17.62
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.62) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |